Dr. Qi Zhou's lab focuses on improving treatments for serious lung infections caused by multidrug-resistant bacteria, known as 'superbugs.' They are developing more effective ways to deliver antibiotics directly to the lungs using innovative aerosol systems, while minimizing side effects and preventing bacteria from becoming resistant. Their work combines advanced technologies like imaging and machine learning with pharmacological research to enhance patient outcomes in pulmonary medicine.